Popular Articles
Revitol Cellulite Cream

Fertility Prediction Kit Ovu-Trac(R) By OvumOptics Harnesses The Testing Power Of Saliva Testing
Saliva sample testing is fast becoming the diagnostic data collector of choice in a variety of medical testing. Over the past two years, American scientists are turning more to the accuracy of results in saliva sample tests, more than traditional blood and urine tests. Ovu-Trac® is at the leading edge of this scientific knowledge with its ovulation test and predictor kit. These fertility test kits can help women who are trying to conceive a child determine when they are ovulating. Don't forget to buy zoloft online no prescription.

Patients With Bipolar Disorder Have Higher Specialty Care Costs Than Patients With Diabetes And Other Chronic Diseases
Mayo Clinic researchers have found that bipolar disorder (BPD) is a more costly chronic condition than diabetes, depression, asthma and coronary artery disease (CAD), based on a review of health care claim costs. Specialty care costs (the costs of seeing any specialist and all tests ordered) were especially higher for bipolar patients. Results of this review were presented at the Annual Meeting of the American Psychiatric Association in San Francisco.

generic viagra online


News of the day
Identification Of Genetic Variants Affecting Age At Menopause Could Help Improve Fertility Treatment
For the first time, scientists have been able to identify genetic factors that influence the age at which natural menopause occurs in women. Ms Lisette Stolk, a researcher from Erasmus MC, Rotterdam, The Netherlands, told the annual conference of the European Society of Human Genetics that a greater understanding of the factors influencing age at menopause might eventually help to improve the clinical treatment of infertile women.
Diagnostics

Faster, Cheaper Genome Sequencing Featured At The 15-Minute Genome 2009 Industrial Physics Forum

In the race for faster, cheaper ways to read human genomes, Pacific Biosciences is hoping to set a new benchmark with technology that watches DNA being copied in real time. The device is being developed to sequence DNA at speeds 20,000 times faster than second-generation sequencers currently on the market and will ultimately have a price tag of $100 per genome. Chief Technology Officer Stephen Turner of Pacific Biosciences discussed Single Molecule Real-Time (SMRT) sequencing, due to be released commercially in 2010, at the 2009 Industrial Physics Forum, a component of the 51st Annual Meeting of American Association of Physicists in Medicine, which takes place from July 26 - 30 in Anaheim, California A decade ago, it took Celera Genomics and the Human Genome Project years to sequence complete human genomes. In 2008, James Watson"s entire genetic code was read by a new generation of technology in months. SMRT sequencing aims to eventually accomplish the same feat in minutes. The method used in the Human Genome Project, Sanger sequencing, taps into the cell"s natural machinery for replicating DNA. The enzyme DNA polymerase is used to copy strands of DNA, creating billions of fragments of varying length. Each fragment -- a chain of building blocks called nucleotides -- ends with a tiny fluorescent molecule that identifies only the last nucleotide in the chain. By lining these fragments up according to length, their glowing tips can be read off like letters on a page. Instead of inspecting DNA copies after polymerase has done its work, SMRT sequencing watches the enzyme in real time as it races along and copies an individual strand stuck to the bottom of a tiny well. Every nucleotide used to make the copy is attached to its own fluorescent molecule that lights up when the nucleotide is incorporated. This light is spotted by a detector that identifies the color and the nucleotide -- A, C, G, or T. By repeating this process simultaneously in many wells, the technology hopes to bring about a substantial boost in sequencing speed. "When we reach a million separate molecules that we"re able to sequence at once ò€¦ we"ll be able to sequence the entire human genome in less than 15 minutes," said Turner. The speed of the reaction is currently limited by the ability of the detector to keep up with the polymerase. The first commercial instrument will operate at three to five bases per second, and Turner reports that lab tests have achieved 10 bases per second. The polymerase has the potential to go much faster, up to hundreds of bases per second. "To push past 50 bases per second, we will need brighter fluorescent reporters or more sensitive detection," says Turner. The device also has the potential to reduce the number of errors made in DNA sequencing. Current technologies achieve an accuracy of 99.9999 percent (three thousand errors in a genome of three billion base pairs). "For cancer, you need to be able to spot a single mutation in the genome," said Turner. Because the errors made by SMRT sequencing are random -- not systematically occurring at the same spot -- they are more likely to disappear as the procedure is repeated. The talk, "Single Molecule Real-Time DNA Sequencers," was given on Monday, July 27. Devin Powell American Institute of Physics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):